Recro Pharma (REPH) Priced

Clinical-stage biotech developing non-opioid therapeutics for the treatment of pain.

Health Care - Biotechnology

IPO Performance
Latest Trade $7.31 0.00 (0.0%)
First Day Return 3.8%
Return from IPO -8.6%
 
Recro Pharma IPO News more
  • .
IPO Data
IPO File Date 10/24/2013
Offer Price $8.00
Price Range $10.00 - $12.00
Offer Shares (mm) 3.8
Deal Size ($mm) 30
 
IPO Data
IPO Date 03/06/2014
Offer Price $8.00
Price Range $10.00 - $12.00
Offer Shares (mm) 3.8
Deal Size ($mm) $30
 
Underwriters
more
Business Overview
Clinical-stage biotech developing non-opioid therapeutics for the treatment of pain.
Clinical-stage biotech developing non-opioid therapeutics for the treatment of pain.
more
Company Data
Headquarters Malvern, PA
Founded 2008
Employees 5
Website www.recropharma.com
 

Performance vs. IPO Index (IPOUSA)